Sartorius | SRT3 - Equity Capital And Reserves

Stock Price
209.70
Daily Change
-5.30 -2.47%
Monthly
-7.21%
Yearly
-15.27%
Q1 Forecast
203.68

Sartorius reported EUR2.67B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 493.4M 53.05M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Moderna USD 8.65B 680M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Sartorius EUR 2.67B 9.9M Sep/2025
Tectonic Therapeutic USD 267.53M 16.24M Sep/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025